Medical Treatment & Drug Development
Post-Doctoral Fellowships
France
Viral engineering for the treatment of neurogenic detrusor overactivity due to spinal cord injury: proof of concept study
This researcher is also supported by the Garches Foundation.
Curing bladder hyperactivity in spinal cord injured patients using gene therapy?
To add or modify information on this page, please contact us at the following address: community.research@axa.com

Pierre
CLEMENT
Institution
Fondation Garches
Country
France
Nationality
French
Related articles
Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Cutaneous neuropathic pain is a highly debilitating chronic condition, characterized by persistent sensations of burning, tingling, or hypersensitivity. It disproportionately... Read more
Celine
GRECO
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Post-Doctoral Fellowship
Germany
Fighting bacterial infection by targeting the ability of pathogens to hijack the body's defense system
Towards developing a new generation of antibiotics that target bacterial ubiquitin ligases used to hijack the host cells Dr. Timurs... Read more

Timurs
MACULINS
Goethe University Frankfurt
Mental Health & Neurology
Medical Treatment & Drug Development
AXA Chair
Spain
Finding a cure to the irreversible damages caused by spinal cord injuries
Building a bridge to restore communication in the spinal cord Our brain communicates with the rest of our body through... Read more

Maurizio
PRATO